BioNano Genomics (0A4K) Share Forecast & Price Target
0A4K Analyst Ratings
0A4K Stock 12 Month Forecast
Average Price Target
$4.00▼(-23.87% Downside)Detailed List of Analyst Forecasts
| Price Target | Follow | Article | ||||||
|---|---|---|---|---|---|---|---|---|
| Jason McCarthy | Maxim Group | $4 | buy | -23.87%Downside | Reiterated | 09/10/26 | ||
| Yi Chen | H.C. Wainwright | $7→$6 | buy | 14.20%Upside | Reiterated | 04/13/26 |
| Price Target | Follow | Article | ||||||
|---|---|---|---|---|---|---|---|---|
| Jason McCarthy | 09/10/26 | $4 | buy | -23.87%Downside | Reiterated | Maxim Group | ||
| Yi Chen | 04/13/26 | $7→$6 | buy | 14.20%Upside | Reiterated | H.C. Wainwright |
Best Analysts Covering BioNano Genomics
Copying Jason McCarthy's trades and holding each position for 3 Months would result in 25.00% of your transactions generating a profit, with an average return of -10.79% per trade.
Copying Jason McCarthy's trades and holding each position for 1 Year would result in 25.00% of your transactions generating a profit, with an average return of -18.04% per trade.
Copying Jason McCarthy's trades and holding each position for 2 Years would result in 25.00% of your transactions generating a profit, with an average return of -17.99% per trade.
0A4K Analyst Recommendation Trends
| Rating | May 26 | Jun 26 | Jul 26 | Aug 26 | Sep 26 |
|---|---|---|---|---|---|
| Strong Buy | 3 | 1 | 1 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 3 | 1 | 1 | 2 | 2 |
In the current month, 0A4K has received 2 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. 0A4K average Analyst price target in the past 3 months is 4.00.
0A4K Financial Forecast
0A4K Earnings Forecast
Next quarter’s earnings estimate for 0A4K is -$0.45 with a range of -$0.45 to -$0.45. The previous quarter’s EPS was -$0.66. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.
0A4K Sales Forecast
Next quarter’s sales forecast for 0A4K is $8.44M with a range of $8.44M to $8.44M. The previous quarter’s sales results were $8.17M. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.
